Platinum Investment Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,902
Closed -$1.67M 126
2025
Q3
$1.67M Buy
16,902
+2,039
+14% +$218K 0.11% 71
2025
Q2
$1.58M Buy
+14,863
New +$1.5M 0.11% 62
2024
Q2
Sell
-41,815
Closed -$3.86M 138
2024
Q1
$3.86M Sell
41,815
-37,737
-47% -$3.62M 0.16% 50
2023
Q4
$8.4M Buy
79,552
+11,214
+16% +$1.13M 0.34% 43
2023
Q3
$7.42M Buy
68,338
+2,500
+4% +$276K 0.29% 42
2023
Q2
$7.11M Buy
65,838
+2,500
+4% +$281K 0.25% 46
2023
Q1
$7.89M Buy
63,338
+24,811
+64% +$3.41M 0.27% 46
2022
Q4
$5.79M Buy
+38,527
New +$5.93M 0.22% 51
2022
Q1
Sell
-7,492
Closed -$1.93M 138
2021
Q4
$1.93M Hold
7,492
0.05% 94
2021
Q3
$2.04M Sell
7,492
-54,567
-88% -$17.3M 0.06% 99
2021
Q2
$13.9M Sell
62,059
-168,208
-73% -$31.7M 0.32% 45
2021
Q1
$25.1M Buy
230,267
+26,128
+13% +$2.77M 0.56% 35
2020
Q4
$16.6M Sell
204,139
-103,058
-34% -$10.1M 0.38% 40
2020
Q3
$21.3M Sell
307,197
-60,591
-16% -$4.35M 0.53% 35
2020
Q2
$24.5M Sell
367,788
-101,778
-22% -$5.08M 0.56% 33
2020
Q1
$24.9M Hold
469,566
0.63% 31
2019
Q4
$14.2M Buy
+469,566
New +$10.5M 0.28% 36

Other funds holding BNTX

Platinum Investment Management's BNTX Position: Q4 2025 in Review

Platinum Investment Management sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 16,902 shares — an estimated $1.67M sold.

Platinum Investment Management first reported a position in BNTX in Q4 2019 and held it in 17 quarters. The position peaked at $25.1M in Q1 2021. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • Platinum Investment Management reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • Platinum Investment Management sold 16,902 BioNTech shares in Q4 2025, an estimated $1.67M.
  • Platinum Investment Management first reported a position in BioNTech in Q4 2019 and held it in 17 quarters.
  • Platinum Investment Management's BioNTech position peaked at $25.1M in Q1 2021.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Platinum Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.